Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Oral levofloxacin and sitafloxacin are effective for the treatment of epididymitis19 September, 2018Pharmacokinetics study on oral levofloxacin (500 mg) and sitafloxacin (100 mg) conducted at the Okoyama University Hospital and its related institutions in Japan demonstrated efficacy for the... -
Levofloxacin: One of the most effective antibiotic for empiric therapy of dacryocystitis13 September, 2018Sensitivity data from a retrospective study investigating the microbiologic profile and antibiogram of patients with acute and chronic dacryocystitis demonstrated levofloxacin as one of the most... -
Secondary switch to oral levofloxacin allowed early rehabilitation in primary ventriculitis caused by Neisseria meningitidis6 September, 2018A four-week antibiotic regimen combining two weeks of intravenous cefotaxime followed by two weeks of oral levofloxacin was shown to be effective in the treatment of meningococcal ventriculitis... -
Long-term levofloxacin demonstrates safety for multidrug-resistant tuberculosis treatment in children29 August, 2018Long-term levofloxacin treatment has demonstrated safety and shown to be well-tolerated in a cohort of seventy children below 15 years of age with multidrug-resistant tuberculosis (MDR-TB). This... -
Prophylactic oral levofloxacin for febrile neutropaenia in acute myeloid leukaemia patients reduces hospital readmissions23 August, 2018Prophylactic oral levofloxacin is shown to be effective for febrile neutropaenia – thereby preventing hospital readmissions in patients with acute myeloid leukaemia (AML) after consolidation... -
Systemic antibiotic treatment with sitafloxacin prevents periodontal surgery-induced stomatitis outbreak16 August, 2018Behçet’s disease (BD) is a systemic vasculitis of unknown aetiology – characterised by recurrent oral and genital ulceration, uveitis, and skin manifestations; epidemiologic studies have... -
Latest Nipah virus outbreak lends urgency to vaccine development10 August, 2018The latest Nipah virus (NiV) outbreak in the Kozhikode and Malappuram districts of Kerala in southern India has claimed 17 lives among the 18 confirmed cases, and resulted in the quarantine of... -
Successful treatment of discitis caused by Aggregatibacter actinomycetemcomitans using empiric levofloxacin: A case report25 July, 2018This is the first published case showing levofloxacin as an effective alternative oral antibiotic for the treatment of discitis caused by the Gram-negative bacillus Aggregatibacter... -
A case of Salmonella Potsdam osteomyelitis treated successfully with levofloxacin and ceftazidime21 July, 2018An extremely rare case of Salmonella Potsdam lumbar vertebral osteomyelitis was treated successfully with intravenous levofloxacin and ceftazidime with symptom improvement and no neurological... -
Estimated cardiac risk associated with macrolides and fluoroquinolones decrease substantially when adjusted for patient characteristics18 July, 2018Researchers at the University of Iowa discovered a decrease in cardiac risk associated with macrolides and fluoroquinolones – when underlying patient characteristics and conditions related to...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Levofloxacin for the Management of Hospital-Acquired, Ventilator-Associated and Healthcare-Associated Pneumonia (Interview with Prof. Marin H. Kollef) -
The Use of Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (Interview with Prof. Hartmut Lode) -
Effect of Combination of Levofloxacin and Meropenem against Pseudomonas aeruginosa (Supervised by Prof. Kazuhiro Tateda, MD, PhD) -
Viewing Infectious Respiratory Disease (Supervised by Prof. Jiro Fujita, MD, PhD, ACCP) -
New Challenges for Levofloxacin in the Fight Against Infectious Diseases (Interviews with World-Renowned Experts) -
New Era for the Treatment of Respiratory Tract infections (Daiichi Pharmaceutical Co., Ltd., Special Interview) -
The Efficacy, Tolerability, and Benefits of 750 mg Once-Daily Levofloxacin in the Treatment of Community-Acquired Pneumonia (Interview with Prof. Thomas M. File, Jr, MD, MS ) -
Smarter Therapy: Guidelines for Optimal Management of Neutropenic Cancer Patients (Interview with Professor Thomas M. File, Jr.) -
Levofloxacin in the Medical Management of Community-acquired Pneumonia (Interview with Prof. Andy I. M. Hoepelman) -
The Way Forward: High-Dose, Short-Course Levofloxacin Leads the Field
UPCOMING EVENTS
23 September - 29 September, 2018
Athens, Greece, Western Europe
26 September - 29 September, 2018
Havana, Cuba, Others
03 October - 07 October, 2018
San Francisco, CA, USA, North America
